PREPAP Study: Tolerance and Effectiveness of the Monoterpenoid Zinc Tetra-ascorbo-camphorate (C14) on the Genital Load of Oncogenic HPV (HR-HPV) and Precancerous Cervical Lesions: Research With Direct Individual Benefit
Latest Information Update: 11 Nov 2024
Price :
$35 *
At a glance
- Drugs Zinc-monoterpenoid-tetra-ascorbo-camphorate-MGB-Pharma (Primary)
- Indications Human polyomavirus infections
- Focus Therapeutic Use
- Acronyms PREPAP
- Sponsors MGB Pharma
- 11 Nov 2024 New trial record